Cellectis SA (CLLS)
1.105
-0.02
(-1.34%)
USD |
NASDAQ |
Oct 15, 16:00
1.11
0.00 (0.00%)
After-Hours: 20:00
Cellectis Cash from Operations (TTM) : -42.00M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -42.00M |
| March 31, 2026 | -38.38M |
| December 31, 2025 | -40.14M |
| September 30, 2025 | -29.93M |
| June 30, 2025 | -34.37M |
| March 31, 2025 | 28.37M |
| December 31, 2024 | 22.14M |
| September 30, 2024 | 62.02M |
| June 30, 2024 | 50.92M |
| March 31, 2024 | -20.30M |
| December 31, 2023 | -25.16M |
| September 30, 2023 | -66.14M |
| June 30, 2023 | -75.06M |
| March 31, 2023 | -79.38M |
| December 31, 2022 | -87.59M |
| September 30, 2022 | -107.49M |
| June 30, 2022 | -111.99M |
| March 31, 2022 | -100.60M |
| December 31, 2021 | -104.92M |
| September 30, 2021 | -117.53M |
| Date | Value |
|---|---|
| June 30, 2021 | -112.55M |
| March 31, 2021 | -122.65M |
| December 31, 2020 | -80.26M |
| September 30, 2020 | -49.26M |
| June 30, 2020 | -46.30M |
| March 31, 2020 | -45.29M |
| December 31, 2019 | -69.14M |
| September 30, 2019 | -86.86M |
| June 30, 2019 | -79.23M |
| March 31, 2019 | -70.56M |
| December 31, 2018 | -68.14M |
| September 30, 2018 | -57.00M |
| June 30, 2018 | -57.53M |
| March 31, 2018 | -54.96M |
| December 31, 2017 | -52.33M |
| September 30, 2017 | -37.30M |
| June 30, 2017 | -27.55M |
| March 31, 2017 | -28.44M |
| December 31, 2016 | -32.70M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| DBV Technologies SA | -169.35M |
| Akari Therapeutics Plc | -10.74M |
| EDAP TMS SA | -- |
| Bicycle Therapeutics Plc | -205.24M |
| argenx SE | 1.160B |